IP Library Granted Patent US 9,993,596
Granted Patent B2
US 9,993,596 · App. 14/099,976 · Granted Jun 12, 2018

Implantable infusion devices including apparatus for confirming side port access

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,993,596
App. No.
14/099,976
Granted
Jun 12, 2018
Kind
B2
Abstract

Implantable infusion devices and systems with side port access detection capability and methods of detecting side port access.

Claims (44)

1. An implantable infusion device, comprising:

a housing;

a reservoir within the housing;

a reservoir refill port on the housing and connected to the reservoir;

a pump mechanism located within the housing and connected to the reservoir;

an outlet port configured to have a catheter connected thereto;

a passageway that connects the outlet port to the pump mechanism;

a catheter access port on the housing and connected to the passageway at a location between the pump mechanism and the outlet port;

a pressure sensor within the housing and connected to the passageway at a location between the pump mechanism and the outlet port; and

means for determining that the catheter access port has been accessed by a needle based on a decrease in pressure in the passageway at the location between the pump mechanism and the outlet port below a baseline pressure measured by the pressure sensor.

2. An implantable infusion device as claimed in claim 1 , further comprising:

a catheter connected to the outlet port.

3. An implantable infusion device as claimed in claim 1 , wherein the pump mechanism comprises an electromagnet pump.

4. An implantable infusion device as claimed in claim 1 , further comprising:

means for generating an audible indication that the catheter access port has been accessed.

5. An implantable infusion device as claimed in claim 1 , wherein the needle comprises a hypodermic needle.

6. An implantable infusion device, comprising:

a housing;

a reservoir within the housing;

a reservoir refill port on the housing and connected to the reservoir;

a pump mechanism located within the housing and connected to the reservoir;

an outlet port configured to have a catheter connected thereto;

a passageway that connects the outlet port to the pump mechanism;

a catheter access port on the housing and connected to the passageway at a location between the pump mechanism and the outlet port;

a pressure sensor within the housing, outside of the catheter access port, and connected to the passageway at a location between the pump mechanism and the outlet port;

an alarm; and

a control apparatus configured to store a pressure sensed by the pressure sensor as a baseline pressure in response to a signal from a remote device, to calculate a low threshold pressure based on the baseline pressure, and to determine that the catheter access port has been accessed by a needle and actuate the alarm if a pressure subsequently sensed by the pressure sensor decreases below the baseline pressure to the low threshold pressure.

7. An implantable infusion device as claimed in claim 6 , wherein the pump mechanism comprises an electromagnet pump.

8. An implantable infusion device as claimed in claim 6 , wherein the catheter access port is configured to receive a hypodermic needle.

9. An implantable infusion device as claimed in claim 6 , further comprising:

a catheter connected to the outlet port.

10. An implantable infusion device system, comprising:

an implantable infusion device including a housing, a reservoir within the housing, a reservoir refill port on the housing and connected to the reservoir, a pump mechanism located within the housing and connected to the reservoir, an outlet port configured to have a catheter connected thereto, a passageway that connects the outlet port to the pump mechanism, a catheter access port on the housing and connected to the passageway at a location between the pump mechanism and the outlet port, and a pressure sensor within the housing and connected to the passageway at a passageway location spaced apart from the catheter access port and between the pump mechanism and the outlet port;

a remote control configured to communicate with the implantable infusion device; and

a control apparatus configured to determine that the catheter access port has been accessed by a needle based on a decrease in pressure below a baseline pressure measured by the pressure sensor.

11. An implantable infusion device system as claimed in claim 10 , wherein the control apparatus is configured to actuate an alarm in response to a determination that the catheter access port has been accessed.

12. An implantable infusion device system as claimed in claim 10 , wherein the catheter access port is configured to receive a hypodermic needle.

13. An implantable infusion device system as claimed in claim 10 , further comprising:

a catheter connected to the outlet port.

14. An implantable infusion device system as claimed in claim 10 , wherein the remote control includes the control apparatus.

15. An implantable infusion device system as claimed in claim 10 , wherein the implantable infusion device includes the control apparatus.

16. An implantable infusion device system as claimed in claim 15 , wherein

the remote control is configured to transmit a catheter access port monitoring initiation signal to the implantable infusion device; and

the control apparatus is configured to store a pressure sensed by the pressure sensor as the baseline pressure in response to the initiation signal, calculate a low threshold pressure based on the baseline pressure, and determine that the catheter access port has been accessed if a pressure subsequently sensed by the pressure sensor decreases to the low threshold pressure.

Assignments (7)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2025
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 071698/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2021
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057798/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: MEDALLION THERAPEUTICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 051287/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDALLION THERAPEUTICS, INC.
Reel/Frame 032892/0067 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE WHICH REFLECTED PATENT NUMBER AS 8,327,041 AND SHOULD HAVE BEEN REFLECTED AS 8,372,041. PREVIOUSLY RECORDED ON REEL 032815 FRAME 0188. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded May 6, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032827/0478 →
SECURITY INTEREST Recorded May 2, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032815/0188 →